The immunosuppression score (ISS), derived from NK cell proportion and HLA-E expression, proved to be a more robust predictor of recurrence and tumor-related mortality compared to NK cell status or HLA-E levels alone. The gene discussed is HLA-E; the disease is neoplasm.